| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Aug―26 |
Design and synthesis of novel triazole based small molecules mimicking HDACi as new modular drugs candidate against Omicron and Future varients of Sars-Cov-2 |
|
| 2 |
[GO] |
2024―Jan―24 |
Investigation on the Binding Affinity of Five Drug-Like Sulphonamides on SARS-CoV-2 Targets: A computational study |
|
| 3 |
[GO] |
2023―Dec―19 |
Virtual screening and molecular docking study of some naturally available phytochemicals against SARS-CoV-2 |
|
| 4 |
[GO] |
2023―Oct―18 |
DE-NOVO DRUG DESIGN OF NOVEL 1,2,3-TRIAZOLE-NAPHTHAMIDE AS AN INHIBITOR OF SARS-COV-2 MAIN PROTEASE: SYNTHESIS, BIOINFORMATICS AND BIOPHYSICAL STUDIES |
|
| 5 |
[GO] |
2023―Jun―19 |
Evaluation of drug likeliness of (Z)-4-((4-hydroxy-3-methoxy benzylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one by computational analysis against coronavirus and T-cells of immune system |
|
| 6 |
[GO] |
2022―Dec―22 |
New Schiff base copper (II) and nickel (II) complexes for biomedical applications with reference to SARS-CoV-2 and HIV virus |
|
| 7 |
[GO] |
2022―Aug―16 |
Structural, spectral, bioactivity, antioxidant and molecular docking (with SARS-CoV-2) analyses on a new synthesized thiosemicarbazide derivative |
|
| 8 |
[GO] |
2022―Aug―08 |
SAR-based approach to explore in silico ferrocene analogues as the potential inhibitors of major viral proteins of SARS-CoV-2 virus and human Ca2+-channel blocker |
|
